167 related articles for article (PubMed ID: 36496454)
1. Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia.
Charpignon ML; Vakulenko-Lagun B; Zheng B; Magdamo C; Su B; Evans K; Rodriguez S; Sokolov A; Boswell S; Sheu YH; Somai M; Middleton L; Hyman BT; Betensky RA; Finkelstein SN; Welsch RE; Tzoulaki I; Blacker D; Das S; Albers MW
Nat Commun; 2022 Dec; 13(1):7652. PubMed ID: 36496454
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus.
Newby D; Linden AB; Fernandes M; Molero Y; Winchester L; Sproviero W; Ghose U; Li QS; Launer LJ; Duijn CMV; Nevado-Holgado AJ
BMJ Open Diabetes Res Care; 2022 Sep; 10(5):. PubMed ID: 36109050
[TBL] [Abstract][Full Text] [Related]
3. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Zhou JB; Tang X; Han M; Yang J; Simó R
Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
[TBL] [Abstract][Full Text] [Related]
4. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
[TBL] [Abstract][Full Text] [Related]
5. Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing.
Hua Y; Zheng Y; Yao Y; Jia R; Ge S; Zhuang A
J Transl Med; 2023 Jun; 21(1):403. PubMed ID: 37344841
[TBL] [Abstract][Full Text] [Related]
6. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
[TBL] [Abstract][Full Text] [Related]
7. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC
J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577
[TBL] [Abstract][Full Text] [Related]
8. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
9. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
[TBL] [Abstract][Full Text] [Related]
10. Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.
Weinstein G; Davis-Plourde KL; Conner S; Himali JJ; Beiser AS; Lee A; Rawlings AM; Sedaghat S; Ding J; Moshier E; van Duijn CM; Beeri MS; Selvin E; Ikram MA; Launer LJ; Haan MN; Seshadri S
PLoS One; 2019; 14(2):e0212293. PubMed ID: 30768625
[TBL] [Abstract][Full Text] [Related]
11. Repurposing old drugs to chemoprevention: the case of metformin.
Heckman-Stoddard BM; Gandini S; Puntoni M; Dunn BK; DeCensi A; Szabo E
Semin Oncol; 2016 Feb; 43(1):123-133. PubMed ID: 26970131
[TBL] [Abstract][Full Text] [Related]
12. Role of metformin in type II diabetes.
Epstein S
Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
[No Abstract] [Full Text] [Related]
13. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
15. Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment.
Zheng B; Su B; Ahmadi-Abhari S; Kapogiannis D; Tzoulaki I; Riboli E; Middleton L
Alzheimers Dement; 2023 Dec; 19(12):5681-5689. PubMed ID: 37395154
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
[TBL] [Abstract][Full Text] [Related]
17. Metformin: Is it a drug for all reasons and diseases?
Triggle CR; Mohammed I; Bshesh K; Marei I; Ye K; Ding H; MacDonald R; Hollenberg MD; Hill MA
Metabolism; 2022 Aug; 133():155223. PubMed ID: 35640743
[TBL] [Abstract][Full Text] [Related]
18. Repurposing metformin for the prevention of cancer and cancer recurrence.
Heckman-Stoddard BM; DeCensi A; Sahasrabuddhe VV; Ford LG
Diabetologia; 2017 Sep; 60(9):1639-1647. PubMed ID: 28776080
[TBL] [Abstract][Full Text] [Related]
19. Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study.
Lee KA; Jin HY; Kim YJ; Kim SS; Cho EH; Park TS
Medicine (Baltimore); 2022 Feb; 101(8):e28823. PubMed ID: 35212277
[TBL] [Abstract][Full Text] [Related]
20. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.
Sharma S; Nozohouri S; Vaidya B; Abbruscato T
Life Sci; 2021 Jun; 274():119343. PubMed ID: 33716063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
